Ncats: service: evaluation of a lead nnmt inhibitor in humanized mouse models of chronic kidney disease: severable
Active Purchase Order Awarded Last action
- Contract number
- 75N98026P01587
- Awardee
-
Gempharmatech LLC UEI H42SCKKGRTU3
- Awarding agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Obligated
- $89,040
Award facts
- Opportunity
-
- Evaluation of a Lead NNMT Inhibitor in Humanized M Solicitation · 75N98026Q00941 · Posted Aug 4, 2026
- Contract value 100% obligated
- $89,040.00 Current and potential, with all options
- Completion date 14% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
The National Center for Advancing Translational Sciences awarded a purchase order to Gempharmatech LLC for $89,040 on September 11, 2026, to evaluate a lead NNMT inhibitor in humanized mouse models of chronic kidney disease.
The order procures three services: recovery and production of 50 male hNNMT homozygous mice from cryopreserved sperm via in vitro fertilization and breeding; efficacy study of the lead NNMT inhibitor in an adenine diet-induced chronic kidney disease model; and efficacy study in a High-Sugar High-Fat Diet combined with Streptozotocin-induced diabetic kidney disease model. Work is performed at NIH/NCATS in Rockville, Maryland. Period of performance runs August 31, 2026, through August 30, 2027. The procurement was awarded on a sole-source basis under FAR 6.302-3(a)(2)(ii) because Gempharmatech developed the humanized NNMT mouse model under prior NIH-funded work and maintains the cryopreserved sperm and breeding resources necessary to regenerate the colony. NAICS code 541714 applies.
Quick answers
Who was awarded contract 75N98026P01587?
75N98026P01587 was awarded to Gempharmatech LLC by Office of Logisitics and Acquisition Operations (National Institutes of Health) on September 11, 2026.
How much is contract 75N98026P01587 worth?
The government has obligated $89,040 on 75N98026P01587.
Which agency awarded contract 75N98026P01587?
Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026P01587, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N98026P01587 competed?
The extent of competition for 75N98026P01587 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award